188 related articles for article (PubMed ID: 31270104)
1. PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia-initiating cells.
Hu T; Morita K; Hill MC; Jiang Y; Kitano A; Saito Y; Wang F; Mao X; Hoegenauer KA; Morishita K; Martin JF; Futreal PA; Takahashi K; Nakada D
Blood; 2019 Aug; 134(7):614-625. PubMed ID: 31270104
[TBL] [Abstract][Full Text] [Related]
2. p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
Zhang J; Kong G; Rajagopalan A; Lu L; Song J; Hussaini M; Zhang X; Ranheim EA; Liu Y; Wang J; Gao X; Chang YI; Johnson KD; Zhou Y; Yang D; Bhatnagar B; Lucas DM; Bresnick EH; Zhong X; Padron E; Zhang J
Blood; 2017 Jan; 129(3):358-370. PubMed ID: 27815262
[TBL] [Abstract][Full Text] [Related]
3. CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice.
Cai Q; Jeannet R; Hua WK; Cook GJ; Zhang B; Qi J; Liu H; Li L; Chen CC; Marcucci G; Kuo YH
Blood; 2016 Sep; 128(11):1503-15. PubMed ID: 27443289
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
Shing DC; Trubia M; Marchesi F; Radaelli E; Belloni E; Tapinassi C; Scanziani E; Mecucci C; Crescenzi B; Lahortiga I; Odero MD; Zardo G; Gruszka A; Minucci S; Di Fiore PP; Pelicci PG
J Clin Invest; 2007 Dec; 117(12):3696-707. PubMed ID: 18037989
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
Mattes K; Geugien M; Korthuis PM; Brouwers-Vos AZ; Fehrmann RSN; Todorova TI; Steidl U; Vellenga E; Schepers H
Exp Hematol; 2019 May; 73():38-49.e7. PubMed ID: 30986495
[TBL] [Abstract][Full Text] [Related]
6. PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation.
Aivalioti MM; Bartholdy BA; Pradhan K; Bhagat TD; Zintiridou A; Jeong JJ; Thiruthuvanathan VJ; Pujato M; Paranjpe A; Zhang C; Levine RL; Viny AD; Wickrema A; Verma A; Will B
Blood Cancer Discov; 2022 Sep; 3(5):444-467. PubMed ID: 35820129
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
[TBL] [Abstract][Full Text] [Related]
8. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
9. Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells.
Aikawa Y; Yamagata K; Katsumoto T; Shima Y; Shino M; Stanley ER; Cleary ML; Akashi K; Tenen DG; Kitabayashi I
Cancer Sci; 2015 Mar; 106(3):227-36. PubMed ID: 25529853
[TBL] [Abstract][Full Text] [Related]
10. The Molecular Signature of Megakaryocyte-Erythroid Progenitors Reveals a Role for the Cell Cycle in Fate Specification.
Lu YC; Sanada C; Xavier-Ferrucio J; Wang L; Zhang PX; Grimes HL; Venkatasubramanian M; Chetal K; Aronow B; Salomonis N; Krause DS
Cell Rep; 2018 Nov; 25(8):2083-2093.e4. PubMed ID: 30463007
[TBL] [Abstract][Full Text] [Related]
11. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
[TBL] [Abstract][Full Text] [Related]
12. USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism.
Melo-Cardenas J; Xu Y; Wei J; Tan C; Kong S; Gao B; Montauti E; Kirsammer G; Licht JD; Yu J; Ji P; Crispino JD; Fang D
Blood; 2018 Jul; 132(4):423-434. PubMed ID: 29844011
[No Abstract] [Full Text] [Related]
13. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
[TBL] [Abstract][Full Text] [Related]
14. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
[TBL] [Abstract][Full Text] [Related]
15. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell.
Shima T; Miyamoto T; Kikushige Y; Yuda J; Tochigi T; Yoshimoto G; Kato K; Takenaka K; Iwasaki H; Mizuno S; Goto N; Akashi K
Exp Hematol; 2014 Nov; 42(11):955-65.e1-5. PubMed ID: 25101977
[TBL] [Abstract][Full Text] [Related]
16. The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.
Shen C; Chen MT; Zhang XH; Yin XL; Ning HM; Su R; Lin HS; Song L; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
PLoS Genet; 2016 Sep; 12(9):e1006259. PubMed ID: 27617961
[TBL] [Abstract][Full Text] [Related]
17. An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages.
Nilsson T; Waraky A; Östlund A; Li S; Staffas A; Asp J; Fogelstrand L; Abrahamsson J; Palmqvist L
Int J Cancer; 2022 Sep; 151(5):770-782. PubMed ID: 35583991
[TBL] [Abstract][Full Text] [Related]
18. A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
Anguita E; Gupta R; Olariu V; Valk PJ; Peterson C; Delwel R; Enver T
Dev Biol; 2016 Mar; 411(2):277-286. PubMed ID: 26851695
[TBL] [Abstract][Full Text] [Related]
19. Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene.
Lai CK; Moon Y; Kuchenbauer F; Starzcynowski DT; Argiropoulos B; Yung E; Beer P; Schwarzer A; Sharma A; Park G; Leung M; Lin G; Vollett S; Fung S; Eaves CJ; Karsan A; Weng AP; Humphries RK; Heuser M
PLoS One; 2014; 9(11):e112671. PubMed ID: 25401736
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Short Variant Form of New Kelch Family Protein Leads to Erythroid and Megakaryocyte Dysplasia by Targeting Megakaryocyte-Erythroid Progenitors.
Lin Y; Luo Y; Hu F; Wang T; Dong Y; Yang D; He X; Chen X; Wang J; Du J; Zhang X
DNA Cell Biol; 2018 Oct; 37(10):831-838. PubMed ID: 30124330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
